PASW
Ping An Biomedical Co., Ltd.
Price Chart
Latest Quote
$4.88
+0.40 (+8.93%)
Current Price
| Previous Close | $4.48 |
| Open | $4.70 |
| Day High | $4.88 |
| Day Low | $4.24 |
| Volume | 50,354 |
Stock Information
Note: Financial values converted from CNY to USD
| Shares Outstanding | 3.13M |
| Total Debt | $1.54M |
| Cash Equivalents | $1.03M |
| Revenue | $3.83M |
| Net Income | $-566K |
| Sector | Consumer Cyclical |
| Industry | Textile Manufacturing |
| Market Cap | $15.26M |
| EPS (TTM) | $-2.38 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $17.44M |
| Sales | $3.83M |
| Income | $-566K |
| Book/sh | $3.74 |
| Cash/sh | $2.19 |
| Employees | 7 |
Financial Ratios
| Quick Ratio | 0.61 |
| Current Ratio | 2.54 |
| Debt/Eq | 13.14 |
Returns & Margins
| ROA | -8.86% |
| ROE | -11.35% |
| Gross Margin | 9.27% |
| Operating Margin | 5.60% |
| Profit Margin | -14.78% |
Ownership
| Insider Ownership | 12.06% |
| Institutional Ownership | 0.27% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.60 |
| P/B | 1.30 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $4.88 |
| SMA50 | $5.16 |
| SMA200 | $6.19 |
| RSI | 50.86 |
| ATR | 1.0139 |
| Shares Float | 1.87M |
| Short Float | 0.44% |
| Short Ratio | 0.03 |
| Rel Volume | 1.32 |
Performance History
| Week | -2.40% |
| Month | -2.40% |
| Quarter | +5.17% |
| 6 Months | -22.78% |
| YTD | -76.31% |
| Year | -83.73% |
| 10 Years | -96.30% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $4.88 | 50,354 |
| 2026-10-26 | $4.48 | 25,900 |
| 2026-10-23 | $4.76 | 241,100 |
| 2026-10-22 | $5.36 | 190,193 |
| 2026-10-21 | $3.68 | 83,015 |
| 2026-10-20 | $5.00 | 4,745 |
| 2026-10-19 | $5.20 | 2,998 |
| 2026-10-16 | $4.80 | 7,445 |
| 2026-10-15 | $5.36 | 4,735 |
| 2026-10-14 | $4.72 | 2,365 |
| 2026-10-13 | $5.04 | 6,808 |
| 2026-10-12 | $4.92 | 5,503 |
| 2026-10-09 | $4.88 | 100,228 |
| 2026-10-08 | $4.60 | 7,195 |
| 2026-10-07 | $4.76 | 4,328 |
| 2026-10-06 | $5.04 | 2,450 |
| 2026-10-05 | $5.08 | 13,833 |
| 2026-10-02 | $5.00 | 1,550 |
| 2026-10-01 | $5.04 | 4,895 |
| 2026-09-30 | $4.96 | 3,268 |
| 2026-09-29 | $4.84 | 7,093 |
| 2026-09-28 | $5.00 | 3,420 |
About Ping An Biomedical Co., Ltd.
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.
đ° Latest News
No news articles available at the moment. Check back later for updates on PASW.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,978,321 | $12,393,313 | $11,745,131 | $15,114,821 |
| Cost Of Revenue | $4,978,321 | $12,327,251 | $11,745,131 | $15,056,369 |
| Total Revenue | $5,120,705 | $13,139,549 | $12,380,972 | $17,177,268 |
| Operating Revenue | $5,120,705 | $13,139,549 | $12,380,972 | $17,177,268 |
| Expenses | ||||
| Interest Expense | $46,045 | $105,760 | $260,963 | $234,891 |
| Total Expenses | $7,325,286 | $13,139,854 | $12,289,126 | $15,505,185 |
| Rent Expense Supplemental | $68,072 | $39,916 | $43,416 | $41,501 |
| Other Income Expense | $-393 | $3,383 | $151,954 | $-195 |
| Other Non Operating Income Expenses | $-393 | $4,188 | $151,954 | $145 |
| Net Non Operating Interest Income Expense | $2,893 | $-105,455 | $-237,549 | $-228,543 |
| Interest Expense Non Operating | $46,045 | $105,760 | $260,963 | $234,891 |
| Operating Expense | $2,346,966 | $812,603 | $543,995 | $448,816 |
| Selling And Marketing Expense | $44,981 | $45,974 | $49,862 | $52,516 |
| General And Administrative Expense | $900,070 | $681,058 | $489,659 | $413,235 |
| Other Operating Expenses | - | - | $-119,965 | $-50,285 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Net Interest Income | $2,893 | $-105,455 | $-237,549 | $-228,543 |
| Interest Income | $48,938 | $305 | $23,415 | $6,349 |
| Normalized Income | $-1,923,823 | $-191,966 | $-149,047 | $1,083,970 |
| Net Income From Continuing And Discontinued Operation | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Total Operating Income As Reported | $-2,204,581 | $-306 | $91,846 | $1,621,799 |
| Net Income Common Stockholders | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Net Income | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Net Income Including Noncontrolling Interests | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Net Income Continuous Operations | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Pretax Income | $-2,202,081 | $-102,378 | $6,251 | $1,443,346 |
| Interest Income Non Operating | $48,938 | $305 | $23,415 | $6,349 |
| Operating Income | $-2,204,581 | $-306 | $91,846 | $1,672,084 |
| Depreciation Amortization Depletion Income Statement | $838 | $67,597 | $62,494 | $62,148 |
| Depreciation And Amortization In Income Statement | $838 | $67,597 | $62,494 | $62,148 |
| Gross Profit | $142,384 | $812,297 | $635,841 | $2,120,899 |
| Per Share | ||||
| Diluted EPS | - | - | $-0.01 | $0.05 |
| Basic EPS | - | - | $-0.01 | $0.05 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-201 | $0 | $-85 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-2,155,198 | $71,785 | $272,126 | $1,740,726 |
| Reconciled Depreciation | $838 | $1,535 | $4,912 | $3,697 |
| EBITDA (Bullshit earnings) | $-2,155,198 | $70,980 | $272,126 | $1,740,386 |
| EBIT | $-2,156,036 | $3,383 | $267,214 | $1,678,237 |
| Diluted NI Availto Com Stockholders | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Tax Provision | $-278,258 | $90,192 | $155,298 | $359,632 |
| Provision For Doubtful Accounts | $1,401,077 | $17,974 | $4,474 | $-28,798 |
| Selling General And Administration | $945,051 | $727,032 | $539,521 | $465,751 |
| Other Gand A | $231,620 | $111,154 | $489,659 | $47,375 |
| Rent And Landing Fees | $68,072 | $39,916 | $43,416 | $41,501 |
| Salaries And Wages | $600,377 | $529,988 | $356,546 | $324,358 |
| Total Unusual Items | - | $-805 | $31,650 | $-340 |
| Total Unusual Items Excluding Goodwill | - | $-805 | $31,650 | $-340 |
| Gain On Sale Of Security | - | $-805 | $31,650 | $-340 |
| Diluted Average Shares | - | - | $3,074,108 | $3,074,108 |
| Basic Average Shares | - | - | $3,074,108 | $3,074,108 |
Fetched: 2026-10-26
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Total Assets | $10,259,204 | $8,524,991 | $11,972,756 | $12,288,638 |
| Total Non Current Assets | $707,357 | $530,792 | $490,375 | $435,717 |
| Non Current Deferred Assets | $637,241 | $408,217 | $409,456 | $408,338 |
| Non Current Deferred Taxes Assets | $637,241 | $408,217 | $409,456 | $408,338 |
| Current Assets | $9,551,847 | $7,994,199 | $11,482,381 | $11,852,921 |
| Current Deferred Assets | $0 | $1,643,707 | $1,131,879 | $737,137 |
| Restricted Cash | $5,327,027 | $0 | - | - |
| Prepaid Assets | $1,396,643 | $235,645 | $628,218 | $116,528 |
| Inventory | $66,266 | $19,089 | $478,201 | $693,702 |
| Receivables | $2,586,090 | $6,076,126 | $9,155,327 | $10,130,625 |
| Other Receivables | $47,194 | $10,596 | $10,024 | $4,868 |
| Accounts Receivable | $2,538,895 | $6,064,436 | $7,061,530 | $8,546,972 |
| Allowance For Doubtful Accounts Receivable | $-2,273,541 | $-1,655,794 | $-1,637,819 | $-1,633,345 |
| Gross Accounts Receivable | $4,812,436 | $7,720,229 | $8,699,349 | $10,180,317 |
| Cash Cash Equivalents And Short Term Investments | $175,821 | $19,633 | $88,755 | $174,930 |
| Cash And Cash Equivalents | $175,821 | $19,633 | $88,755 | $174,930 |
| Cash Financial | $175,821 | $19,633 | - | - |
| Taxes Receivable | - | - | - | $0 |
| Debt | ||||
| Net Debt | $1,323,744 | $1,479,932 | $6,284,396 | $5,148,526 |
| Total Debt | $1,569,681 | $1,621,303 | $6,441,612 | $5,333,465 |
| Long Term Debt And Capital Lease Obligation | $14,351 | $69,198 | $10,008 | $0 |
| Current Debt And Capital Lease Obligation | $1,555,331 | $1,552,105 | $6,431,604 | $5,333,465 |
| Current Debt | $1,499,565 | $1,499,565 | $6,373,152 | $5,323,456 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,474,870 | $9,602,905 | $12,851,440 | $11,598,907 |
| Total Non Current Liabilities Net Minority Interest | $14,351 | $69,198 | $10,008 | $0 |
| Current Liabilities | $3,460,520 | $9,533,708 | $12,841,432 | $11,598,907 |
| Current Deferred Liabilities | $10,463 | $250,949 | $79,676 | $40,885 |
| Payables And Accrued Expenses | $1,894,726 | $7,730,654 | $6,330,152 | $6,224,557 |
| Interest Payable | $0 | $2,653 | $31,564 | $47,339 |
| Payables | $1,887,715 | $7,698,635 | $6,298,588 | $6,177,218 |
| Other Payable | $3,115 | $7,569 | $7,210 | $3,450 |
| Total Tax Payable | $33,012 | $100,812 | $90,854 | $380,439 |
| Accounts Payable | $1,411,602 | $2,257,718 | $1,390,455 | $2,704,520 |
| Dividends Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Total Equity Gross Minority Interest | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Stockholders Equity | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Gains Losses Not Affecting Retained Earnings | $10,261 | $153,369 | $106,962 | $21,577 |
| Other Equity Adjustments | $10,261 | $153,369 | $106,962 | $21,577 |
| Retained Earnings | $-3,156,197 | $-1,232,374 | $-986,737 | $667,064 |
| Other Equity Interest | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $3,074,108 | $3,074,108 | $3,074,108 | $3,074,108 |
| Share Issued | $3,074,108 | $3,074,108 | $3,074,108 | $3,074,108 |
| Tangible Book Value | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Invested Capital | $8,283,899 | $421,651 | $5,494,468 | $6,013,188 |
| Working Capital | $6,091,327 | $-1,539,508 | $-1,359,051 | $254,015 |
| Capital Lease Obligations | $70,116 | $121,738 | $68,460 | $10,008 |
| Total Capitalization | $6,784,333 | $-1,077,915 | $-878,684 | $689,732 |
| Additional Paid In Capital | $9,929,010 | $0 | - | $0 |
| Capital Stock | $1,259 | $1,090 | $1,090 | $1,090 |
| Common Stock | $1,259 | $1,090 | $1,090 | $1,090 |
| Long Term Capital Lease Obligation | $14,351 | $69,198 | $10,008 | $0 |
| Current Deferred Revenue | $10,463 | $250,949 | $79,676 | $40,885 |
| Current Capital Lease Obligation | $55,766 | $52,540 | $58,452 | $10,008 |
| Line Of Credit | $1,499,565 | $1,499,565 | $6,373,152 | $5,323,456 |
| Current Accrued Expenses | $7,011 | $32,019 | $31,564 | $47,339 |
| Dueto Related Parties Current | $439,985 | $5,332,535 | $4,810,069 | $3,088,809 |
| Net PPE | $70,116 | $122,575 | $80,919 | $27,379 |
| Accumulated Depreciation | $-14,884 | $-14,046 | $-12,511 | $-7,599 |
| Gross PPE | $85,000 | $136,621 | $93,430 | $34,979 |
| Other Properties | $70,116 | $121,738 | $78,546 | $20,095 |
| Machinery Furniture Equipment | $14,884 | $14,884 | $14,884 | $14,884 |
| Finished Goods | $66,266 | $19,089 | $478,201 | $693,702 |
| Duefrom Related Parties Current | $0 | $1,095 | $2,083,774 | $1,578,785 |
Fetched: 2026-10-26
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-963,885 | $2,193,897 | $-912,161 | $3,158,583 |
| Operating Activities | ||||
| Operating Cash Flow | $-963,885 | $2,193,897 | $-912,161 | $3,162,298 |
| Cash Flow From Continuing Operating Activities | $-963,885 | $2,193,897 | $-912,161 | $3,162,298 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $2,249,348 | $-504,989 | $-4,537,609 |
| Cash Flow From Continuing Investing Activities | $0 | $2,249,348 | $-504,989 | $-4,537,609 |
| Net Other Investing Changes | - | $2,249,348 | $-504,989 | $-4,533,893 |
| Capital Expenditure | - | - | - | $-3,716 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $16,223,420 | $0 | $0 | $1,090 |
| Financing Cash Flow | $6,547,165 | $-4,512,027 | $1,330,814 | $1,535,242 |
| Cash Flow From Continuing Financing Activities | $6,547,165 | $-4,512,027 | $1,330,814 | $1,535,242 |
| Net Other Financing Charges | $-4,657,696 | - | - | $-1,746,539 |
| Cash Dividends Paid | $0 | $-48,348 | $-1,440,142 | $-724,325 |
| Common Stock Dividend Paid | $0 | $-48,348 | $-1,440,142 | $-724,325 |
| Net Common Stock Issuance | $16,223,420 | $0 | $0 | $1,090 |
| Common Stock Issuance | $16,223,420 | $0 | $0 | $1,090 |
| Other | ||||
| Repayment Of Debt | $-14,307,285 | $-12,467,763 | $-9,562,285 | $-10,675,024 |
| Issuance Of Debt | $9,288,726 | $8,004,084 | $12,333,240 | $12,933,501 |
| Interest Paid Supplemental Data | $46,620 | $105,760 | $292,528 | $223,241 |
| Income Tax Paid Supplemental Data | $0 | $33,120 | $318,557 | $286,283 |
| End Cash Position | $5,502,848 | $19,633 | $88,755 | $174,930 |
| Beginning Cash Position | $19,633 | $88,755 | $174,930 | $15,852 |
| Effect Of Exchange Rate Changes | $-100,065 | $-340 | $162 | $-854 |
| Changes In Cash | $5,583,280 | $-68,783 | $-86,336 | $159,932 |
| Net Issuance Payments Of Debt | $-5,018,559 | $-4,463,679 | $2,770,955 | $2,258,477 |
| Net Short Term Debt Issuance | $-5,018,559 | $-4,463,679 | $2,770,955 | $1,049,907 |
| Short Term Debt Payments | $-14,307,285 | $-12,467,763 | $-9,562,285 | $-6,276,388 |
| Short Term Debt Issuance | $9,288,726 | $8,004,084 | $12,333,240 | $7,326,296 |
| Net PPE Purchase And Sale | $0 | $0 | $0 | $-3,716 |
| Purchase Of PPE | $0 | $0 | $0 | $-3,716 |
| Change In Working Capital | $-212,033 | $2,364,177 | $-771,381 | $2,096,488 |
| Change In Other Working Capital | $-240,486 | $171,273 | $38,791 | $-209,434 |
| Change In Payables And Accrued Expense | $-943,961 | $878,606 | $-1,615,665 | $1,925,490 |
| Change In Accrued Expense | $-48,611 | $-37,891 | $-139,460 | $225,076 |
| Change In Payable | $-895,350 | $916,497 | $-1,476,205 | $1,700,413 |
| Change In Account Payable | $-846,116 | $867,263 | $-1,314,065 | $1,634,263 |
| Change In Tax Payable | $-49,234 | $49,234 | $-162,140 | $66,150 |
| Change In Income Tax Payable | $-49,234 | $49,234 | $-162,140 | $66,150 |
| Change In Prepaid Assets | $-1,107,008 | $-123,568 | $-890,976 | $-159,440 |
| Change In Inventory | $-46,258 | $458,192 | $215,501 | $1,707,846 |
| Change In Receivables | $2,125,680 | $979,674 | $1,480,968 | $-1,167,974 |
| Changes In Account Receivables | $2,124,463 | $979,120 | $1,480,968 | $-1,167,974 |
| Provisionand Write Offof Assets | $1,400,157 | $19,515 | $4,474 | $-28,798 |
| Deferred Tax | $-229,024 | $1,240 | $-1,119 | $7,198 |
| Deferred Income Tax | $-229,024 | $1,240 | $-1,119 | $7,198 |
| Depreciation Amortization Depletion | $838 | $1,535 | $4,912 | $3,697 |
| Depreciation And Amortization | $838 | $1,535 | $4,912 | $3,697 |
| Depreciation | $838 | $1,535 | $4,912 | $3,697 |
| Net Income From Continuing Operations | $-1,923,823 | $-192,570 | $-149,047 | $1,083,714 |
| Net Long Term Debt Issuance | - | - | $1,721,260 | $1,208,569 |
| Long Term Debt Payments | - | - | $-4,238,828 | $-4,398,636 |
| Long Term Debt Issuance | - | - | $5,960,088 | $5,607,205 |
Fetched: 2026-10-26